Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. The World Health Organization late ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

At least five candidates are in the running to become the next director-general of the WHO, a job that will come with ...

The Justice Department said in June that it would no longer enforce laws that prioritized people with disabilities living and ...

Heidi Overton, President Trump’s nominee to lead the Food and Drug Administration, was grilled by senators on hot-button ...

Virtually all of the 175,000 public comments on a 2022 FDA proposal to ban menthol cigarettes were form letters, most echoing ...

Advanced Research Projects Agency for Health is planning a total-lifespan research project on autism: A Q&A with its leader, ...

We’ve come a long way since the fall of 2001, but we find ourselves with recent widening gaps in public health readiness and mitigation,” writes Daniel B. Jernigan.

President Trump’s nominee to lead the FDA was grilled by senators on hot button topics like China, vaccines, and abortion ...

Klomp is currently senior adviser to health secretary Robert F. Kennedy Jr. He was advanced by the Senate Committee on ...

Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand ...